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ABSTRACT 
Salt formation is used to optimize pharmaceutical properties for carboxylic acid drugs but 
selection can often be empirical. An extended series of salts of the anti-hyperlipidaemia 
carboxylic acid drug gemfibrozil was prepared using related series of amine counterions to gain a 
molecular insight into the impact of crystal packing arrangements on their physicochemical 
properties. With only a few exceptions, the salts had similar crystal packing motifs. Although 
there was no discernible relationship between melting point of the salt form and the aqueous 
solubility of the salt across the whole dataset, there were trends within structurally-related series 
of salts relating increasing melting enthalpy with increasing molecular weight of the counter ion. 
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INTRODUCTION 
The crystal structure of an active pharmaceutical ingredient (API) will impact its 
physicochemical and mechanical properties, thus determining solubility, dissolution, stability, 
bioavailability and ultimately its successful application as a therapeutic agent.  New chemical 
entities obtained by targeted drug design and combinatorial chemistry or high-throughput 
screening techniques often exhibit unfavourable qualities, most commonly low aqueous 
solubility and in vivo dissolution rate, while some show high hygroscopicity or other physical or 
chemical stability risks.  Additional challenges in the development and manufacturing of 
potential APIs include undesirable physical and mechanical properties of the drug crystals and 
powder that can lead to difficulties during the processes of milling, filling, and compaction. 
Approaches that have been used to try to overcome these problems include salt formation1 - 5, 
crystallization solvent and conditions optimization, particle size reduction, or formation of solid 
dispersions, solid-lipid nanoparticle dispersions and complexation (e.g. with cyclodextrins)6,7.   
Although salt formation is a widely-used strategy to improve solubility of ionisable drugs3, 5, 8, 9, 
the choice of counterion for formation of the salt will potentially not only influence the 
physicochemical properties like solubility, but will likely also have an impact on the physical 
and mechanical properties of the drug.  We have been particularly interested in the effects of 
amine counterions on the properties of carboxylic acid drugs, including crystal structure, 
solubility and other physicochemical properties and compaction behaviour10 – 13, as well as 
potential for impact on drug absorption through improved aqueous solubility.  The favourable 
impact of the formation of diamine salts on the relative oral bioavailability of the anti-
hyperlipidaemia carboxylic acid drug gemfibrozil has been demonstrated14. Understanding if and 
how salt form choices could be used to optimize pharmaceutical properties for carboxylic acid 
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drugs such as gemfibrozil would allow early selection and so speed clinical development for this 
class of compounds.  We have therefore now extended the counterion range investigated for 
gemfibrozil (Fig. 1), beyond that we have previously studied11,12 and also re-examined the 
previously investigated salt forms further, in order to gain additional understanding of molecular 
conformation and packing within the crystal and the influence on crystal properties. 
EXPERIMENTAL SECTION 
Materials 
Gemfibrozil was pharmacopoeial grade (DiPharma, Italy) and tert-butylamine, tromethamine 
(tris), 2-amino-2-methylpropan-1-ol (AMP1), 2-amino-2-methylpropan-1,3-diol (AMP2) 
benzylamine, cyclopropylamine, cyclobutylamine, cyclohexylamine, octylamine, hexylamine, 
butylamine, triethanolamine, and adamantamine were analytical grade materials supplied by 
Sigma-Aldrich (Poole, UK).  Acetonitrile and methanol were HPLC grade materials supplied by 
Fisher (Loughborough, UK). 
Methods 
Salt preparation 
Crystalline salts were prepared by mixing equimolar amounts of drug and counterion dissolved 
in acetonitrile and recovering the precipitated salt by filtration under vacuum or by holding at -
4°C until precipitate formed before filtration.  Recovered salt precipitates were recrystallized 
from methanol.  Salt formation was confirmed by nuclear magnetic resonance spectroscopy 
(NMR) and Fourier-transform infra-red spectroscopy (FTIR) and salt crystallinity examined by 
differential scanning calorimetry (DSC), looking for a sharp melting endotherm as indication of 
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production of a crystalline salt. 1-H NMR spectra were recorded on samples dissolved in 
deuterated chloroform on a Bruker AC 250 NMR (250 MHz) with a MAC Quadra 800 PC using 
WIN-NMR version 3.0 software.  FTIR analysis of the drug or salt in KBr was carried out using 
a Unicam Mattson 3000 over 4000–400 cm−1 with Galaxy software. DSC was performed using a 
calibrated Perkin Elmer PYRIS Diamond DSC. Each sample (3–5 mg) was accurately weighed 
and heated under nitrogen in vented pans at a scan rate of 10°C/min from 0°C to a temperature 
exceeding the melting point or a maximum of 250°C.  FTIR, DSC and powder XRD data for the 
prepared salts are included in the supplementary information, Figs S1 – S5. 
Single crystal and powder X-ray diffractometry (XRD) 
Single-crystal X-ray diffraction data on the following five salts of gemfibrozil were collected at 
the National Crystallography Service, Southampton, UK:  adamantylammonium (GAdam), 
benzylammonium (GBenz), cyclobutylammonium (GCbut), cyclohexylammonium (GChex) and 
triethanolammonium (GTea).  Diffraction maxima, with MoKα (λ = 0.71073 Å) radiation 
produced by a rotating anode generator, were collected with an area detector to a maximum Θ 
approximately 27.5°.  Multi-scan absorption corrections were applied with SADABS15.  
Structures were solved by direct methods with SHELXS16, revealing all non-hydrogen atoms. 
Non-hydrogen atom positions and anisotropic displacement parameters were refined with 
SHELXL2014/717.  Hydrogen atoms were assumed to ride on their attached atom, primary 
ammonium and methyl groups being allowed to rotate.  Final discrepancy indices R(obs) reached 
0.0851, 0.0498, 0.0603, 0.0442 and again 0.0442 for the five structures respectively.  
Crystallographic Information Files have been deposited with the Cambridge Crystallographic 
Data Centre.  
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Physicochemical properties 
Melting points and melting enthalpies were determined by DSC as outlined above. True densities 
were measured by helium pycnometry using a Gemini pycnometer (Micromeritics, Dunstable, 
UK) that was calibrated prior to use.   To determine saturated solubility and solution pH, excess 
salt or free acid was added to double distilled water in a glass vial, the vial sealed and the 
contents stirred for 48 hours at ambient conditions (20 - 22°C) or in a water bath at 37°C.  The 
supernatant solution in the vial was filtered through a 0.45μm PTFE syringe filter, pH measured 
using a pH meter with a glass electrode and the solution was then diluted for high-performance 
liquid chromatography analysis (HPLC). HPLC was undertaken using an Agilent 1100 series 
system (Agilent Technologies, Wokingham, UK) with a G1312A binary pump, a G1313A ALS 
autoinjector (injection volume 1μl), a G1316A COLCOM column section ad a G1314A VWD 
variable wavelength detector set at 276 nm.  Mobile phase was acetonitrile:water 65/35 v/v with 
0.005% v/v phosphoric acid, delivered at 1 ml/min to a 15 cm x 4.6 mm C18 reverse phase 
column (ODS-2 Hypersil 5μm, ThermoScientific, Hemel Hempstead, UK).  
 
RESULTS AND DISCUSSION 
Salt formation was confirmed by NMR and FTIR and all salts were confirmed as the expected 
1:1 stoichiometry by NMR. No hydrates or solvates were identified as being formed based on 
thermal analysis data.  Salts were found to be crystalline by DSC and powder XRD, although the 
butylamine, hexylamine, octylamine and cyclopropylamine salts were poorly crystalline as 
evidenced by their broad DSC melting endotherm and broad diffraction peaks on the powder 
XRD pattern.  This limited the information we were able to develop for these compounds. 
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Crystal structures of gemfibrozil amine salts 
The crystallography of gemfibrozil free acid has been described previously18 as have the crystal 
structures for the tert-butylamine, AMP1, AMP2 and tris salts, determined from powder XRD 
data, using the direct-space Genetic Algorithm technique and Rietveld refinement11.  
Crystallographic data for the new adamantylamine, benzylamine, cyclobutylamine, 
cyclohexylamine, and triethanolamine salts are given in table 1.  Refinement parameters were 
satisfactory, apart from the value of R(int) of 17.96 found for the adamantylammonium salt.  
This was attributed to the difficulty in preparing large crystals of this salt and that the best crystal 
available used for crystal structure determination at approximately 0.2mm x 0.04mm x 0.01mm 
did result in a less than ideal signal to noise ratio.  Repeating the refinement without the 
reflections above theta 25.25 degrees decreased the R(int) to 17.31%, a small improvement. 
However, R factors for the agreement between observed and calculated data showed more 
improvement: wR2 dropped from 20.18% to 18.43% and the R factor for observed reflections 
went from 8.43% to 7.84%. Therefore, the determination of crystal structure was achieved for 
this salt, despite the rather small crystal size.  Hydrogen bonding distances are provided in the 
supplementary information, Table S1. 
 
For efficient packing within the crystal, gemfibrozil molecules must arrange to find interaction 
partners for the highly polar carboxylic acid or carboxylate group and the bulky nonpolar 
dimethylphenyl group.  They can be kept well separated if the alkoxy chain adopts an all-trans 
conformation.  The free acid has a monoclinic unit cell where the asymmetric unit is formed of 
two molecules with hydrogen bonding between the carboxylic acid groups. The geometric 
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parameters of the two molecules of the asymmetric unit are very similar.  Essentially, the alkoxy 
chain adopts an extended conformation, the non-H atoms (excluding those of the carboxylic 
acids and the α-methyl groups) lying more or less in a plane with the carboxylate group turned 
perpendicular to the plane of the side chain (Fig. 2a). 
 
For the amine salts studied in this work, taking the cyclohexylammonium salt (Fig. 3) as 
representative, the torsion angles along the alkoxy side chain are defined as set out in table 2, 
where of the two carboxylate oxygen atoms, O1 is the one which defines a torsion angle with 
magnitude ≤90°.  To provide more compact descriptors of the chain conformation the distances 
between the ether oxygen atom O3 and the carboxylate oxygen atoms O1 and O2 are tabulated 
(O…O distances, table 2).   In the case of the free acid, all torsion angles are trans apart from 
TOR5 and TOR6, which are gauche. With only a few exceptions the salts show a similar pattern 
of torsion angles and distance of the ether oxygen O3 from the carboxylate oxygens O1 and O2. 
In the tris salt and both anions in the butane-1,4-diammonium salt14 TOR3 is gauche but TOR5 
is trans, providing a measure of compensation. Still, this change can enlarge the difference in 
ether to carboxylate O…O distances:  in the case of the tris salt one O…O distance is the longest 
in the entire set while the other one is among the shortest. TOR3 in the tert-butylammonium salt 
is unlike any others. 
To further explore these results for a wider range of structures with similar features, the 
conformation determined for the gemfibrozil anion in the cyclohexylammonium salt was 
employed as the query structure in torsion angle absolute values searches with the Cambridge 
Crystallographic Data Centre Mogul tool19.  For the cyclohexylammonium salt, and hence all the 
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salts investigated except tert-butylammonium, tris and, as reported by others14  butane-1,4-
diammonium, the torsion angles TOR1, TOR2, TOR3 and TOR4 fall within the most populated 
ranges (trans), whilst TOR 5 is gauche - as are most of the comparison structures (Fig. 4).  No 
preference is evident for TOR6.  In the case of the tris and butane-1,4-diammonium salts, TOR3 
is gauche, which is an alternate frequently populated range for this structure, but the angle for 
TOR3 in the case of the tert-butylammonium salt TOR3 is not within the frequently populated 
ranges. Hence the alkoxy chain in the tert-butylammonium salt of gemfibrozil is the most 
removed from a straight conformation (Fig. 2b).  
 
For the unit cells, most of the salts, like the free acid, have one short cell axis in the range 6.2 – 
6.5Å, which may indicate the presence of a common crystal packing motif (Table 3).  For the 
free acid, the short cell axis is larger at 7.36Å, and this is also the case with the tris salt at 10.04Å 
and also the triethanolammonium salt, where the short cell axis is 7.12Å.  Except for the cases of 
the triethanolammonium and tris salts (see later), the common short axis arises, as previously 
described for the tert-butylammonium, AMP1 and AMP2 salts, from chains of alternating 
gemfibrozil anions and amine cations linked by N-HˑˑˑO (more correctly N+–H…O-, although in 
this paper, for simplicity, we have not indicated ionized forms in identifying specific discussed 
groups) hydrogen bonds11, with adjacent chain having cross-links in the form of N-H…O 
hydrogen bonds resulting in a ladder like structure.  The “frame” of the ladder is made of 
hydrogen bonds backed up by the alternating hydrophobic and hydrophilic domains of cation and 
anion, and the “rungs” are the between chain hydrogen bonds.  The two chains of the ladder and 
the adjacent pair of hydrogen bonds form a hydrogen bonded ring11.  The primary aliphatic 
amine salts adamantylammonium, cyclobutylammonium and cyclohexylammonium salts have 
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ladders of R4
3  (10) rings (Fig. 5) as previously described for the tert-butylammonium salt
11.  In 
every case, the ammonium group donates one hydrogen bond to a carboxylate oxygen adjacent 
to it in its chain, another to OCO– along the chain and a third to OCO–  along the “rung”, related 
by a twofold screw axis; the H…O contact distances for all the salts investigated are remarkably 
uniform within a range of 1.80 to 1.89Å (Table S1).  The benzylammonium salt instead has 
ladders of R4
2(8) and R4
4(12) rings (Fig. 6), which may be engendered by the need to 
accommodate the aromatic ring into the packing motif.   Generated around inversion centres, the 
rings here also have H…O distances within the narrow ranges seen for the primary aliphatic 
amine salts (Table S1).  For the alicyclic amines, the alkyl groups of the cation approach the 
gemfibrozil aliphatic chain, whereas the benzene ring of the cation in the benzylammonium salt 
is located edge-on in close proximity to the aromatic ring of gemfibrozil.  This packing 
arrangement results in the ring structure and the more compact unit cell of the benzylammonium 
salt relative to the alicyclic ammonium salts.  The two most commonly occurring hydrogen 
bonded supramolecular assemblies for chiral ammonium carboxylate salts in the Cambridge 
Structural Database are the ladders of R4
3  (10) rings for homochiral salts and ladders of R4
2(8) and 
R4
4(12) rings for heterochiral ammonium salts20 the former also referred to as Type II chains and 
the latter as Type III chains21.  In our salts, we see these commonly observed structures with 
achiral cations and anions and within the Cambridge Structural Database the Type II structure 
was seen equally with achiral and chiral ammonium ions (salts with achiral carboxylic acids).     
Additional hydrogen bonding or halogen bonding opportunities within the asymmetric unit due 
to the counterion can lead to the disruption of these most common ladder structures with impact 
on the physicochemical properties of the salts11, 20.  
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Table 3 also presents the volume per asymmetric unit and the Kitaigorodski packing index 
calculated with PLATON22.  As expected, a bulkier cation generally leads to a larger volume of 
the asymmetric unit, but this trend can be modified by packing efficiency.  Thus, the series of 
salts tert-butylamine, AMP1, AMP2 exhibits a decrease in asymmetric unit volume for each 
step, even though OH is replacing one H each time.  The extra hydrogen bonding between chains 
significantly improves the packing efficiency.  That the tert-butylammonium salt has the lowest 
packing index of the entire group may be related to distortion observed in TOR3. 
 
As with the hydroxyl substituted derivatives of tert-butylamine (i.e. AMP1, AMP2 and tris)11, 
triethanolamine as a counterion offers opportunity for additional hydrogen bonding within the 
unit cell beyond the cross linking of the alternating cation and anion adjacent chains as seen in 
the aliphatic and alicyclic amine salts.  The triethanolamine hydroxyl groups are hydrogen 
bonded to the carboxylate oxygens of gemfibrozil. In the protonated cation two of the H-N-C-C 
torsion angles are gauche (-38° and -41°) and one, H1-N1-C20-C21, is trans (-174°).  Steric 
hindrance appears to block the approach of a gemfibrozil anion.in N-H…OCO hydrogen 
bonding, which would be assisted by electrostatic interaction between the carboxylate oxygens 
and the protonated, positively charged nitrogen of the amine.  Instead, the narrow window 
opened on one side by the positioning of the C20-C21-O6-H6 ethanol moiety allows cation-
cation interaction around an inversion centre via N-H…O hydrogen bonding to a neighbouring 
hydroxyl group (Fig 7).  Participation of every polar H atom in hydrogen bonds may help to 
explain the relatively high Kitaigorodski packing index of this structure (Table 3).  A search of 
the Cambridge Structural Database for salts formed between carboxylic acids and 
triethanolamine revealed structure determinations of 14 different salts, comprising 17 
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independent ion pairs.  In 12 of the cations all three H-N-C-C torsion angles are gauche, 
precluding any intermolecular N-H…O hydrogen bonding except with the blade-like 
cymantrenecarboxylate ion23.  In the other 5 cations, as in the present structure, one of these 
torsion angles is trans.  Of these 5 cations, one forms paired N-H…OH dimers, 3 form N-
H…OH chains and one leaves the NH unused.  Without a single exception, all N-C-C-O torsions 
are gauche.   The hydrogen bonding structure adopted in the triethanolammonium salt prevents 
the formation of ladders as with the majority of the other salts we have investigated. Similarly, 
with its ability to form additional hydrogen bonding within the unit cell conferred by multiple 
hydroxyl group substitution on the amine counterion, the tris salt also does not adopt a ladder-
like arrangement11. 
 
The effect on crystal packing of systematically varying the length of the alkyl chain in diamine 
salts (of the form H2N(CH2)nNH2, where n = 3, 4 or 5) of gemfibrozil has also been described 
previously14, where each ammonium group is associated with a gemfibrozil carboxylate anion, 
with some similar observations to the monoamine salts reported here.  When n = 3, these groups 
form the familiar ladders of (10) rings along the b axis, connected to adjacent ladders via (18) 
rings, thereby creating a supramolecular sheet.  Increasing n to 4 or 5 opens up the structure, 
allowing for inclusion of two water molecules into each asymmetric unit that participate in 
hydrogen bonding.  Hydrates were not found in the case of the monoamine salts in this work. 
 
Overall, salt formation led to an increase in density, the exceptions being the linear amine salts, 
and the greatest effect being seen with those salts that had additional opportunity for hydrogen 
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bonding within the unit cells.  This increase in density correlated reasonably well with, unit cell 
volume and the packing index.  As denser crystals might help with, for example, accommodating 
higher doses of drug into acceptable tablet sizes, forming a salt with greater density might be an 
advantage.  Choosing a counterion that provides for increased hydrogen bonding might be of 
value in this situation, as salts where increased hydrogen bonding was possible in the unit cell 
tended to have the greater densities, although the resulting density advantage might be negated 
by the greater mass required in using the salt form to deliver a specific dose of the active free 
acid. 
 
Although for a limited series of salts previously described in the literature8, by excluding two of 
the six data pairs, Gould was able to demonstrate a linear relationship between log10 solubility 
and the reciprocal of the absolute melting temperature1.   Others have also had success in 
identifying solubility-melting point relationships for drug salts24, 25, 26, yet there are examples 
where a correlation was not observed4, 27, 28.  Examining our data for the solubility of amine salts 
of gemfibrozil (Table 4), we were unable to observe an overall trend or demonstrate a 
relationship between melting point of the salt form and the aqueous solubility of the salt.  This is 
despite having an extended set of salts in the current set over our previous work.  Solubility is a 
complex phenomenon dependent not only on the strength of lattice energy which must be 
overcome to enable the compound to go into solution and the ability of the molecule going into 
solution to engage in interactions with solvent molecules, but in the case of salts for the 
counterion to also similarly interact with the solvent and so facilitate salt solubility. 
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Within structurally-related counterion series of salts from the overall set there were however 
possible trends, with increased melting point with increasing molecular weight for the cyclic 
amine counterions cyclopropylamine, cyclobutylamine, cyclohexylamine yet a decrease in 
melting point with increasing molecular weight for the linear amine counterions butylamine, 
hexylamine, octylamine.  However, in both these series there was a trend to increasing melting 
enthalpy with increasing molecular weight of the counterion.  A possible explanation invokes the 
fact that at equilibrium the Gibbs free energy change ΔG = ΔH – TΔS must be zero.  For the 
constrained cyclic amines there is a relatively small entropy increase upon breaking up the 
crystal.  As ΔH increases for the larger cations, T must increase so that TΔS can match it.  For 
the linear amine counterions there is a larger positive ΔS which becomes more pronounced for 
the longer chains, requiring a smaller T to offset ΔH.  This line of reasoning is supported by 
thermodynamic data29 for the parent hydrocarbons of the amines.  In the series propyl, butyl, 
hexyl, octyl the entropy of fusion in J K-1 mol-1 is 37.4, 45.2, 45.8, 49.0 for the cyclo-alkanes but 
spans the much wider range 41.3, 54.0, 73.2, 95.8 for the open-chain alkanes. 
 
CONCLUSION 
A series of amine salts of the carboxylic acid drug, gemfibrozil, was prepared, crystal structures 
determined and physicochemical properties measured. Like the free acid, most of the salts, have 
one short cell axis, leading to a common crystal packing motif, with a ladder-like arrangement. A 
bulkier counterion generally leads to a larger volume of the asymmetric unit, but this trend was 
modified by packing efficiency.  Counterions affording opportunities for additional hydrogen 
bonding within the unit cell, triethanolamine and tris, hamper formation of this common motif.  
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Based on the results in this study, it can be concluded that, although salt formation increases 
solubility for all the counterions studied, it is not possible to make wide-ranging predictions of 
solubility based on the properties of the counterion used, although there are trends within 
structurally-related series. A thorough examination of the crystal arrangements within the 
different series provides a rational explanation for the different physicochemical properties 
determined. 
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Table 1. Crystallographic data for gemfibrozil amine salts 
 GAdam GBenz   GCbut GChex GTea 
Empirical formula C25H39NO3 C22H31NO3   C19H31NO3 C21H35NO3 C21H37NO6 
Molecular weight 401.57 357.48   321.45 349.50 399.51 
Temperature (K) 120 120   120 120 120 
Wavelength (Å) 0.71073 0.71073   0.71073 0.71073 0.71073 
Crystal system Orthorhombic Triclinic   Orthorhombic Monoclinic Monoclinic 
Space group P212121 P -1   P212121 P21/n P21/c 
a (Å) 6.5081(4) 6.1974(3)   6.1793(4) 9.5074(6) 18.0782 (3) 
b (Å) 10.5426(7) 12.7063(7)   9.3558(5) 6.5298(3) 7.10680(10) 
c (Å) 34.282(3) 12.9893(6)   33.270(2) 32.936(2) 18.5776(4) 
α (°) 90 91.917(2)   90 90 90 
β (°) 90 95.769(3)   90 90.340(2) 112.3770(10) 
γ (°) 90 95.241(3)   90 90 90 
V (Å3) 2352.2(3) 1012.48(9)   1923.4(2) 2044.7(2) 2207.08(7) 
Z 4 2   4 4 4 
ρ (g cm−3) 1.134 1.173   1.110 1.135 1.202 
μ (mm−1) 0.073 0.077   0.074 0.074 0.087 
F(000) 880 388   704 768 872 
GooF 0.990 1.038   1.044 1.062 1.019 
Reflections/data/parameters 21489/5111/268  21229/4631/244   11402/4300/213 12577/4117/232 36961/5060/261 
Rint 0.1796 0.0594   0.0472 0.0361 0.0577 
Final R indices (I > 2σ(I)) R1 = 0.0851 R1 = 0.0500   R1 = 0.0603 R1 = 0.0442 R1 = 0.0420 
 wR2 = 0.1430 wR2 = 0.1125   wR2 = 0.1308 wR2 = 0.1051 wR2 = 0.1039 
Final R indices (all data) R1 = 0.2453 R1 = 0.0790   R1 = 0.0754 R1 = 0.0615 R1 = 0.0609 
 wR2 = 0.2018 wR2 = 0.1258   wR2 = 0.1410 wR2 = 0.1156 wR2 = 0.1139 
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Table 2.  Alkoxy side chain torsion angles (to nearest degree) * for gemfibrozil free acid and 
amine salts 
 
Gemfibrozil salt TOR1 TOR2 TOR3 TOR4 TOR5 TOR6 ShortOOa LongOOa 
Free acid a 179 -177 -178 -174 -55b -68b 5.47 5.61 
Free acid b 179 180 -177 -176 -53b -60b 5.42 5.69 
tert-butylammonium -140b -172 -111b -158 -44b 93b 5.31 5.49 
AMP1 salt 164 -163 -156 170 29b 53b 5.17 5.84 
AMP2 salt 166 -166 180 166 -60b -68b 5.44 5.51 
tris salt -171 -179 -64b -174 -171 51b 5.22 6.32 
adamantylammonium 177 177 -173 -167 59b 62b 5.42 5.53 
benzylammonium 176 -175 -168 -178 67b 70b 5.55 5.87 
cyclobutylammonium -175 168 174 169 49b 54b 5.18 5.59 
cyclohexylammonium -179 -178 -177 -169 -50b -58b 5.39 5.63 
triethanolammonium -177 -171 -171 -165 -64b 48b 5.32 5.89 
 
*The definition of torsion angles follows the numbering scheme illustrated in Figure 3 for the cyclohexylammonium 
salt, where the carboxylate oxygen atoms O1 and O2 are numbered such that the magnitude of TOR6 is ≤90° or the 
smaller of the two possible values:  TOR1 =  C13-C8-O3-C7, TOR2 = C8-O3-C7-C6, TOR3 = O3-C7-C6-C5, 
TOR4 = C7-C6-C5-C2, TOR5 = C6-C5-C2-C1, TOR6 = C5-C2-C1-O1. 
a = distances from O3 to O2/O1 
b = Torsion angle outside the antiperiplanar range. 
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Table 3.  Unit cell dimensions for gemfibrozil free acid and amine salts* 
Gemfibrozil salt a (Å) b (Å) c (Å) Cell Volume 
(Å3) 
Asymmetric 
unit volume 
(Å3) 
Packing Index 
(%) 
Free acid  14.86 7.36 27.95 3053.1 382 62.0 
tert-butylammonium 6.45 9.68 33.10 2066.1 517 61.8 
AMP1 salt 26.88 6.37 23.92 4092.8 512 64.4 
AMP2 salt 27.08 6.32 22.89 3918.0 490 68.9 
tris salt 18.50 10.04 11.00 2014.9 506 67.0 
adamantylammonium 6.51 10.54 34.28 2352.2 588 65.5 
benzylammonium 6.20 12.71 12.99 1012.5 506 67.9 
cyclobutylammonium 6.18 9.36 33.27 1923.4 481 65.2 
cyclohexylammonium 9.51 6.53 32.94 2044.7 511 67.4 
triethanolammonium 18.08 7.11 18.58 2207.1 552 67.9 
*Hydrogen bond information is provided as part of the supplementary information 
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Table 4.  Physicochemical properties of gemfibrozil salts 
Salt counterion Density 
(g/cm3) 
Melting 
point (°C) 
Enthalpy of 
fusion 
(kJ/mole) 
Aqueous solubility 
(mg/ml) 
pH of solution 
(ambient 
temperature samples) 
    20 - 22°C 37°C  
none 1.09 61.2 25.2 0.039 0.002 4.62 
butylamine 1.07 71.3 9.4 35.9 $ 8.70 
hexylamine 0.98 68.6 11.7 3.73 $ 7.80 
octylamine 0.75 49.2 19.5 0.88 $ 7.50 
benzylamine 1.13 94.3 28.0 1.73 4.41 8.32 
cyclohexylamine 1.14 134.2 30.4 3.20 2.36 7.37 
t-butylamine 1.04 133.6 30.4 11.03 7.82 7.78 
AMP1 1.10 107.4 31.5 16.62 * 7.89 
AMP2 1.21 119.7 44.3 25.2 13.16 8.10 
tris 1.22 122.1 47.4 6.97 28.50 7.60 
cyclopropylamine 1.14 85.0 7.5 4.28 14.24 8.02 
cyclobutylamine 1.12 105.0 20.8 4.28 20.39 8.06 
1-adamantylamine 1.14 192.9 37.7 0.19 0.59 5.96 
triethanolamine 1.16 97.1 44.1 16.64 7.87 7.71 
* > 300 mg/mL saturation not achieved with limited amount of material available.  $forms oily dispersion on 
shaking excess of salt with water at 37°C which solidifies and precipitates out on cooling to yield original salt 
form. 
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Figure 1. Structure of gemfibrozil  
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Figure 2. (a) Gemfibrozil, free acid form, in the unit cell viewed from the plane of the aromatic 
ring, (b) Gemfibrozil, from its tert-butylammmonium salt form, in the unit cell viewed from the 
plane of the aromatic ring to show effect of counterion on side chain conformation. 
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Figure 3. Gemfibrozil cyclohexylammonium salt 
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Figure 4.  Frequency plots based on data in the Cambridge Structural Database for torsion angles 
examined in gemfibrozil and its amine salts, determined using CSSD Mogul. Query values marked are for 
cyclohexylammonium salt. 
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Figure 4. (continued) 
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Figure 5. Crystal structure for gemfibrozil adamantylammonium salt (top), gemfibrozil 
cyclobutylammonium salt (centre) and gemfibrozil cyclohexylammonium salt (bottom), with hydrogen 
bonds indicated by blue connectors to show the ladders of R4
3  (10) rings supramolecular assembly. 
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Figure 6. Crystal structure of gemfibrozil benzylammonium salt, with hydrogen bonds indicated 
by blue connectors to show the ladders of R4
2(8) and R4
4(12) rings supramolecular assembly. 
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Figure 7. Crystal structure of gemfibrozil triethanolammonium salt, with hydrogen bonds 
indicated by blue connectors showing this salt does not exhibit the ladders of rings 
supramolecular assembly seen in many of the other amine salts. 
 
